Dividends
NUS

Nu Skin Enterprises, Inc. (NUS) Ex-Dividend Date Scheduled for August 27, 2020

Nu Skin Enterprises, Inc. (NUS) will begin trading ex-dividend on August 27, 2020. A cash dividend payment of $0.375 per share is scheduled to be paid on September 09, 2020. Shareholders who purchased NUS prior to the ex-dividend date are eligible for the cash dividend payment. This marks the 3rd quarter that NUS has paid the same dividend. At the current stock price of $48.43, the dividend yield is 3.1%.

The previous trading day's last sale of NUS was $48.43, representing a -0.7% decrease from the 52 week high of $48.77 and a 293.58% increase over the 52 week low of $12.31.

NUS is a part of the Health Care sector, which includes companies such as McKesson Corporation (MCK) and AmerisourceBergen Corporation (Holding Co) (ABC). NUS's current earnings per share, an indicator of a company's profitability, is $2.68. Zacks Investment Research reports NUS's forecasted earnings growth in 2020 as -3.03%, compared to an industry average of -8.1%.

For more information on the declaration, record and payment dates, visit the NUS Dividend History page. Our Dividend Calendar has the full list of stocks that have an ex-dividend today.

Interested in gaining exposure to NUS through an Exchange Traded Fund [ETF]?
The following ETF(s) have NUS as a top-10 holding:

  • First Trust Cons. Staples AlphaDEX (FXG)
  • Cambria ETF Trust (SYLD)
  • WisdomTree U.S. SmallCap Dividend Fund (DES)
  • Avantis U.S. Small Cap Value ETF (AVUV)
  • ProShares Trust (REGL).

The top-performing ETF of this group is AVUV with an increase of 55.03% over the last 100 days. FXG has the highest percent weighting of NUS at 3.86%.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

NUS

NASDAQ.com

Nasdaq

Get the latest stock market news, stock information & quotes, data analysis reports, as well as a general overview of the market landscape from Nasdaq.

Read Nasdaq.com's Bio